Purchase Order HHSN272201200768P
- Not listed
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. The $5,636.16 contract is for the delivery of Illumina's sequencing systems, reagents, and services to support genomic research and analysis. Illumina, a manufacturer of genetic analysis instruments and consumables, has previously been awarded prime contracts and sub-awards across various federal agencies...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The contract, valued at $4,037.50, is for the delivery of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, and support services. The contract has no set-aside designation....
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The contract, valued at $12,875.00, is for sequencing services to support NIAID's research and diagnostic efforts. Illumina has previously been awarded other prime federal contracts and subcontracts by...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The $3,409.10 contract is for the provision of sequencing systems, reagents, consumables, and related support services to support genomic research and diagnostics. Illumina has a history of prior prime federal contract and...
- This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer and provider of genetic and genomic analysis solutions. The $5,834.40 order is for the provision of Illumina's sequencing instruments, reagents, and services, including NextSeq, NovaSeq, MiSeq, and iSeq systems. These products and services support genomic sequencing and analysis for...
- This firm fixed-price purchase order contract was awarded to Illumina, Inc. by the National Institute of Allergy and Infectious Diseases (NIAID) on September 16, 2015 for $19,603.58. The contract, which does not have a set-aside designation, is for the provision of Illumina's sequencing systems, reagents, and consumables to support genomic sequencing and analysis for research and diagnostic purposes. Illumina has previously received prime federal contracts and sub-awards from agencies such as...
- This is a $752,450 firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample prep kits, sequencing chips, support plans, maintenance services, and bioinformatics products. This contract...
- This is a firm fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of Illumina biomedical sequencing instruments and related materials. The $7,998.65 contract is for the purchase of Illumina's sequencing systems, reagents, and consumables to support genomic research and diagnostics. Illumina is a leading manufacturer of genetic analysis...
- This is a $8,080.64 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The contract is not associated with a set-aside program. Illumina has previously provided sequencing systems, consumables, and services to support genomic research and diagnostics for various federal agencies including the NIH, CDC, USDA, and VA. This particular...
- This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $6,829.94 contract does not have a set-aside designation. Illumina has previously received federal prime contracts and subcontracts from agencies like the Centers for Disease Control and Prevention (CDC), Department of...
This is a $6,935.22 firm fixed-price purchase order contract awarded to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions, by the National Institute of Allergy and Infectious Diseases (NIAID), an agency of the National Institutes of Health (NIH). The contract, which has no set-aside designation, is for the provision of sequencing systems, reagents, and services to support genomic research and diagnostics across various federal agencies. Illumina has previously served as a prime contractor and subcontractor on similar awards from the NIH, CDC, USDA, VA, and Department of the Navy, supplying a range of its NextSeq, NovaSeq, MiSeq, and iSeq platforms and related consumables, software, and services. The contract has a completion date of September 10, 2012.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 8/24/12 |